Teruki Yanagi

2.3k total citations
112 papers, 1.1k citations indexed

About

Teruki Yanagi is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, Teruki Yanagi has authored 112 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 37 papers in Dermatology and 33 papers in Molecular Biology. Recurrent topics in Teruki Yanagi's work include Cancer and Skin Lesions (20 papers), Nonmelanoma Skin Cancer Studies (17 papers) and Cancer-related Molecular Pathways (10 papers). Teruki Yanagi is often cited by papers focused on Cancer and Skin Lesions (20 papers), Nonmelanoma Skin Cancer Studies (17 papers) and Cancer-related Molecular Pathways (10 papers). Teruki Yanagi collaborates with scholars based in Japan, United States and Greece. Teruki Yanagi's co-authors include Hiroshi Shimizu, Shinya Kitamura, Shu‐ichi Matsuzawa, John C. Reed, Hiroo Hata, Riichiro Abe, Keisuke Imafuku, Hiroshi Nishihara, Takuya Maeda and Shinya Tanaka and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Teruki Yanagi

101 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teruki Yanagi Japan 20 448 291 259 234 203 112 1.1k
Piotr Dziunycz Switzerland 22 687 1.5× 578 2.0× 309 1.2× 331 1.4× 86 0.4× 42 1.7k
Cornelia S. Seitz Germany 18 407 0.9× 178 0.6× 351 1.4× 109 0.5× 118 0.6× 43 1.3k
Qinlong Zheng Denmark 23 457 1.0× 255 0.9× 36 0.1× 296 1.3× 115 0.6× 46 1.6k
Haiyan Chu China 23 353 0.8× 68 0.2× 119 0.5× 151 0.6× 87 0.4× 41 1.1k
Terufumi Kubo Japan 20 477 1.1× 504 1.7× 129 0.5× 62 0.3× 70 0.3× 92 1.3k
Knuth Rass Germany 15 399 0.9× 332 1.1× 247 1.0× 78 0.3× 96 0.5× 54 1.1k
Phyllis F. Cheung Hong Kong 19 303 0.7× 330 1.1× 303 1.2× 123 0.5× 33 0.2× 36 1.5k
A. Brocard France 21 295 0.7× 727 2.5× 505 1.9× 505 2.2× 46 0.2× 51 1.4k
Ei Kawahara Japan 22 459 1.0× 419 1.4× 28 0.1× 173 0.7× 132 0.7× 77 1.4k
B. M. Czarnetzki Germany 16 360 0.8× 319 1.1× 208 0.8× 55 0.2× 113 0.6× 49 1.1k

Countries citing papers authored by Teruki Yanagi

Since Specialization
Citations

This map shows the geographic impact of Teruki Yanagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teruki Yanagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teruki Yanagi more than expected).

Fields of papers citing papers by Teruki Yanagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teruki Yanagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teruki Yanagi. The network helps show where Teruki Yanagi may publish in the future.

Co-authorship network of co-authors of Teruki Yanagi

This figure shows the co-authorship network connecting the top 25 collaborators of Teruki Yanagi. A scholar is included among the top collaborators of Teruki Yanagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teruki Yanagi. Teruki Yanagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujisawa, Yasuhiro, Kenjiro Namikawa, Koji Yoshino, et al.. (2025). Phase II trial dedicated to non-selected, pretreated cutaneous angiosarcoma: Efficacy of nivolumab (AngioCheck Study). European Journal of Cancer. 224. 115537–115537. 1 indexed citations
2.
Yanagi, Teruki, Takuya Maeda, Hiroshi Nishihara, et al.. (2024). Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism. British Journal of Cancer. 131(5). 944–953. 2 indexed citations
3.
Yanagi, Teruki, et al.. (2023). Current understanding of comparative pathology and prospective research approaches for canine hemangiosarcoma. Research in Veterinary Science. 167. 105120–105120. 1 indexed citations
4.
Yanagi, Teruki, Takuya Maeda, Hiroshi Nishihara, et al.. (2023). Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft. Scientific Reports. 13(1). 8650–8650. 5 indexed citations
5.
Inaba, Yutaka, Nobuo Kanazawa, Kayo Kunimoto, et al.. (2022). Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study. Children. 9(3). 310–310. 14 indexed citations
6.
Maeda, Takuya, et al.. (2022). Adjuvant nivolumab therapy may not improve disease‐free survival in resected acral lentiginous melanoma patients: A retrospective case series. Dermatologic Therapy. 35(11). e15817–e15817. 4 indexed citations
7.
Ghazawi, Feras M., Ryuta Tanaka, Yasuhiro Fujisawa, et al.. (2020). Demographic and clinical characteristics of extramammary Paget's disease patients in Japan from 2000 to 2019. Journal of the European Academy of Dermatology and Venereology. 35(2). e133–e135. 14 indexed citations
8.
Yanagi, Teruki, Masashi Watanabe, Hiroo Hata, et al.. (2018). Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma. Cancer Research. 78(24). 6795–6806. 40 indexed citations
9.
Imafuku, Keisuke, et al.. (2016). Modified Dufourmentel flap, easy to design and tailor to the defect. The Journal of Dermatology. 44(1). 68–70. 5 indexed citations
10.
Yanagi, Teruki, Maryla Krajewska, Shu‐ichi Matsuzawa, & John C. Reed. (2014). PCTAIRE1 Phosphorylates p27 and Regulates Mitosis in Cancer Cells. Cancer Research. 74(20). 5795–5807. 50 indexed citations
11.
Ιtο, Yukako, Mizuki Goto, Yutaka Hatano, et al.. (2011). A Case of Harlequin Ichthyosis. The Nishinihon Journal of Dermatology. 73(1). 26–30. 2 indexed citations
14.
Akiyama, Masashi, Kaori Sakai, Chitoshi Takayama, et al.. (2008). CGI-58 Is an α/β-Hydrolase within Lipid Transporting Lamellar Granules of Differentiated Keratinocytes. American Journal Of Pathology. 173(5). 1349–1360. 22 indexed citations
15.
Yanagi, Teruki, et al.. (2007). Bullous pemphigoid associated with dermatomyositis and colon carcinoma. Clinical and Experimental Dermatology. 32(3). 291–294. 11 indexed citations
16.
Yanagi, Teruki, et al.. (2007). Relapsing Polychondritis and Malignant Lymphoma. Archives of Dermatology. 143(1). 89–90. 25 indexed citations
17.
Kato, Naoko, et al.. (2007). A case of Bockenheimer's syndrome (genuine diffuse phlebectasia): venous involvement inside muscles was detected by magnetic resonance imaging. Clinical and Experimental Dermatology. 32(6). 664–667. 2 indexed citations
18.
Yanagi, Teruki, Tadamichi Shimizu, Riichiro Abe, & Hiroshi Shimizu. (2005). Zinc dental fillings and palmoplantar pustulosis. The Lancet. 366(9490). 1050–1050. 40 indexed citations
19.
Yanagi, Teruki, et al.. (2004). Effects of Ion Microbeam Irradiation on Silica Glass. Transactions of the Materials Research Society of Japan. 29. 603–606. 2 indexed citations
20.
Goto, Mizuki, et al.. (2002). Vegetative pyoderma gangrenosum in chronic renal failure. British Journal of Dermatology. 146(1). 141–143. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026